Why Rocket Lab Stock Is Losing Altitude Today

Piper Sandler initiated coverage of Rocket Lab (RKLB) with a neutral rating and an $83 price target, implying 8.9% upside from $76.20, but the stock was down 12.1% at 2:14 p.m. ET. The firm expects Rocket Lab to trade at a premium to SpaceX and sees similar valuation over the next year, but still frames the call as not an immediate catalyst. In contrast, Piper Sandler initiated bullish coverage on AST SpaceMobile with a $100 target versus $66.31, implying ~51% upside, likely shifting relative sentiment within space stocks.

Analysis

This is less a fundamental downdraft than a valuation reset triggered by external anchoring. In a name like RKLB, where the shareholder base is disproportionately momentum- and narrative-driven, a neutral initiation can still compress the multiple because it signals the stock is no longer being underwriting as a pure scarcity story. The key mechanism is relative valuation: once the market is told the premium is "fair," upside depends almost entirely on near-term execution beats, not on rerating.

The second-order winner is ASTS, not because the setup is pristine, but because capital is being steered toward a higher-beta, more asymmetrical endpoint with a clearer "optionality" premium. That trade works best if the market keeps rewarding long-duration service revenue over launch-heavy hardware economics. The risk is that ASTS remains a financing and milestone story; any slip in deployment or dilution over the next 1-3 months would rapidly unwind the relative outperformance.

For RKLB, the pain could extend beyond today if the next catalyst cycle fails to show faster launch cadence or gross margin leverage. The stock is vulnerable to a short-duration de-rating because the new target leaves only modest upside, so buy-the-dip demand may be thin until the next print. Contrarian view: this could be overdone if investors mistake a neutral coverage initiation for a downgrade; if management can reaffirm 2025-26 operating leverage, the gap down may be a tradable shakeout rather than a structural break.

Key Decisions for Investors

• Initiate a beta-neutral long ASTS / short RKLB pair on weakness over the next 1-3 sessions; target relative outperformance of 10-15% if the market continues rotating toward higher-optionality space names. Risk: exit if ASTS loses milestone credibility or RKLB reclaims the post-note gap on volume.
• If already long RKLB, trim 25-50% into any intraday rebound and replace with ASTS exposure; the better risk/reward is in the name with more rerating potential and less dependence on near-term launch execution.
• Do not press an outright short in RKLB immediately; use a failed rebound above the pre-drop range as the trigger. Falsifier: a strong upcoming operational update or guidance raise that restores confidence in margin expansion and backlog conversion.